Monoclonal antibodies for the treatment of COVID‐19 in a patient with high‐risk acute leukaemia - Aix-Marseille Université Access content directly
Journal Articles British Journal of Haematology Year : 2022

Dates and versions

hal-03813942 , version 1 (21-09-2023)

Identifiers

Cite

Paul Saultier, Laetitia Ninove, Sarah Szepetowski, Mathilde Veneziano, Sandrine Visentin, et al.. Monoclonal antibodies for the treatment of COVID‐19 in a patient with high‐risk acute leukaemia. British Journal of Haematology, 2022, 196 (1), pp.E1-E3. ⟨10.1111/bjh.17756⟩. ⟨hal-03813942⟩
15 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More